Satisfaction with glucose-lowering treatment and well-being in patients with type 2 diabetes and myocardial infarction: A DIGAMI2 QoL sub-study

Laura Venskutonyte; Kerstin Brismar; Tina Rydén-Bergsten; Lars Rydén; Barbro Kjellström

doi:10.1177/1479164112463711

Satisfaction with glucose-lowering treatment and well-being in patients with type 2 diabetes and myocardial infarction: A DIGAMI2 QoL sub-study

Diabetes and Vascular Disease Research ◽

10.1177/1479164112463711 ◽

2012 ◽

Vol 10 (3) ◽

pp. 263-269 ◽

Cited By ~ 3

Author(s):

Laura Venskutonyte ◽

Kerstin Brismar ◽

Tina Rydén-Bergsten ◽

Lars Rydén ◽

Barbro Kjellström

Keyword(s):

Myocardial Infarction ◽

Type 2 Diabetes ◽

Well Being ◽

Glucose Lowering

Download Full-text

The impact of glucose lowering treatment on long-term prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial

European Heart Journal ◽

10.1093/eurheartj/ehm518 ◽

2007 ◽

Vol 29 (2) ◽

pp. 166-176 ◽

Cited By ~ 106

Author(s):

L. G. Mellbin ◽

K. Malmberg ◽

A. Norhammar ◽

H. Wedel ◽

L. Ryden ◽

...

Keyword(s):

Myocardial Infarction ◽

Type 2 Diabetes ◽

Glucose Lowering ◽

Long Term Prognosis ◽

The Impact

Download Full-text

The frequency and timing of acute myocardial infarction onset in patients with type 2 diabetes, depending on the glucose-lowering therapy

Russian Heart Journal ◽

10.18087/rhj.2017.4.2372 ◽

2017 ◽

Vol 17 (4) ◽

pp. 260-267

Author(s):

S. V. Kakorin ◽

◽

I. A. Averkova ◽

A. M. Mkrtumyan ◽

G. G. Melkonyеn ◽

...

Keyword(s):

Myocardial Infarction ◽

Type 2 Diabetes ◽

Acute Myocardial Infarction ◽

Glucose Lowering ◽

Lowering Therapy ◽

Glucose Lowering Therapy

Download Full-text

Dynamics of indicators of cytolysis, carbonyl stress in patients with type 2 diabetes and non-alcoholic fatty liver disease on glucose-lowering therapies

Endocrine Abstracts ◽

10.1530/endoabs.70.ep218 ◽

2020 ◽

Author(s):

Rodionova Svetlana ◽

Zvenigorodskaya Larissa ◽

Biryukova Elena ◽

Petrakov Alexander ◽

Nilova Tamara

Keyword(s):

Type 2 Diabetes ◽

Liver Disease ◽

Fatty Liver ◽

Fatty Liver Disease ◽

Carbonyl Stress ◽

Alcoholic Fatty Liver ◽

Glucose Lowering ◽

Alcoholic Fatty Liver Disease

Download Full-text

438-P: Comparative Cardiovascular Effectiveness of Glucagon-Like Peptide-1 Receptor Agonists vs. Other Glucose-Lowering Agents in Patients with Type 2 Diabetes—A Nationwide Cohort Study Using Prevalent New-User Design

Diabetes ◽

10.2337/db19-438-p ◽

2019 ◽

Vol 68 (Supplement 1) ◽

pp. 438-P

Author(s):

CHUN-TING YANG ◽

CHENYI YANG ◽

SHIHCHEN KUO ◽

HUANG-TZ OU

Keyword(s):

Type 2 Diabetes ◽

Cohort Study ◽

Glucose Lowering ◽

Receptor Agonists ◽

User Design ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Faculty Opinions recommendation of The Bypass Angioplasty Revascularization Investigation 2 Diabetes randomized trial of different treatment strategies in type 2 diabetes mellitus with stable ischemic heart disease: impact of treatment strategy on cardiac mortality and myocardial infarction.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717966957.793502404 ◽

2014 ◽

Author(s):

Athanasios Manolis

Keyword(s):

Diabetes Mellitus ◽

Myocardial Infarction ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Heart Disease ◽

Treatment Strategies ◽

Cardiac Mortality ◽

Disease Impact ◽

Bypass Angioplasty Revascularization Investigation

Download Full-text

Influence of Type 2 diabetes Mellitus with and without cardiovascular disease or myocardial infarction on levels of calcium, sodium, and some vital variables in Iraqi men

10.36295/asro.2020.232132 ◽

2020 ◽

Vol 23 (19) ◽

Author(s):

Safa S. Fayez ◽

Rashid M. Rashied ◽

Shakir F.T. Alaaraji

Keyword(s):

Diabetes Mellitus ◽

Myocardial Infarction ◽

Type 2 Diabetes ◽

Cardiovascular Disease ◽

Type 2 Diabetes Mellitus

Download Full-text

Efficacy and Safety of Eight Classes of Glucose-Lowering Agents as Monotherapy for Type 2 Diabetes: A Systematic Review and Indirect Treatment Comparison

SSRN Electronic Journal ◽

10.2139/ssrn.3539644 ◽

2020 ◽

Author(s):

Shuyan Gu ◽

Xueshan Sun ◽

Xiaoqian Hu ◽

Lizheng Shi ◽

Minzhuo Huang ◽

...

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Efficacy And Safety ◽

Glucose Lowering ◽

Indirect Treatment Comparison ◽

Treatment Comparison ◽

Indirect Treatment

Download Full-text

Impact of Glucose-Lowering Drugs on Mortality and Other Adverse Outcomes in Patients with Type 2 Diabetes Admitted for COVID-19

SSRN Electronic Journal ◽

10.2139/ssrn.3666251 ◽

2020 ◽

Author(s):

Luis Miguel Pérez-Belmonte ◽

José David Torres-Peña ◽

María D. López-Carmona ◽

M. Mar Ayala-Gutiérrez ◽

Francisco Fuentes-Jiménez ◽

...

Keyword(s):

Type 2 Diabetes ◽

Adverse Outcomes ◽

Glucose Lowering

Download Full-text

CYTOKINE DYSBALANCE IN TYPE 2 DIABETES MELLITUS PATIENTS WITH PRIOR MYOCARDIAL INFARCTION

PROBLEMS OF ENDOCRINE PATHOLOGY ◽

10.21856/j-pep.2016.4.01 ◽

2016 ◽

pp. 7-13

Author(s):

N. V. Altunina ◽

Keyword(s):

Diabetes Mellitus ◽

Myocardial Infarction ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Prior Myocardial Infarction

Download Full-text

THE FEATURES OF ACUTE MYOCARDIAL INFARCTION IN PATIENTS WITH TYPE 2 DIABETES AND OBESITY BEFORE AND AFTER REPERFUSION THERAPY

PROBLEMS OF ENDOCRINE PATHOLOGY ◽

10.21856/j-pep.2015.1.04 ◽

2015 ◽

pp. 28-35

Author(s):

O. M. Bilovol ◽

◽

P. P. Kravchun ◽

O. I. Kadykova ◽

◽

...

Keyword(s):

Myocardial Infarction ◽

Type 2 Diabetes ◽

Acute Myocardial Infarction ◽

Reperfusion Therapy ◽

Before And After ◽

Diabetes And Obesity

Download Full-text